Letters, Testimony & Comments

February 24, 2014
Dear Sir or Madam:   The Pharmaceutical Research and Manufacturers of America (PhRMA) and Biotechnology Industry Organization (BIO) are pleased to submit these comments in response to the Food and Drug Administration’s (FDA’s...
February 12, 2014
On behalf of the Biotechnology Industry Organization (BIO), I hereby submit comments on the Senate Committee on Finance staff discussion draft to reform certain energy tax provisions. BIO is the world's largest trade association representing...
February 12, 2014
The Honorable David Borden, Committee Chair The Honorable Charles Townsend, Committee Vice-Chair And the Members of the Science, Technology & Energy Committee: Chairman Borden, Vice Chairman Townsend, and Members of the Committee, the...
February 3, 2014
 Dear Sir/Madam: The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to submit comments on the “Draft Guidance for Industry on Pharmacy Compounding of Human Drug Products...
January 31, 2014
Dear Ms. Badrov:   The Biotechnology Industry Organization (BIO) and the Illinois Biotechnology Industry Organization (iBIO) appreciate this opportunity to comment on the Illinois Department of Healthcare and Family Services (the “...
January 31, 2014
Dear Ms. Gibson: To Whom It May Concern: The Biotechnology Industry Organization (BIO) appreciates this opportunity to comment on the Texas Health and Human Services Commission (HHSC) proposed rule regarding 340B program reimbursement (the...
January 31, 2014
Dear Sir/Madam: The Biotechnology Industry Organization (BIO) respectfully submits these comments in response to the Generic Pharmaceutical Association (GPhA) Citizen Petition requesting the Food and Drug Administration (FDA) to “implement...
January 29, 2014
  January 28, 2014   The Honorable Gina McCarthy Administrator, Environmental Protection Agency Air and Radiation Docket and Information Center Mailcode: 2822T 1200 Pennsylvania Avenue NW Washington, DC  20460   Docket...
January 22, 2014
 Dear Commissioner Hamburg and Director Burwell: On behalf of the member companies of Biotechnology Industry Organization (BIO), we respectfully request that the Office of Management and Budget (OMB) issue the proposed Food and Drug...
January 21, 2014
Advancing Bioscience Industry Growth in Michigan: 2014 Best Practice Legislative Strategies To the Honorable Members of the 2014 Michigan Legislature: Thank you for providing BIO an opportunity to speak with you this morning and offer best...
January 3, 2014
 Dear Sir/Madam: The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to submit comments on the “Proposed Rule: Permanent Discontinuance or Interruption in Manufacturing of...
December 19, 2013
On November 15, 2013, BIO submitted comments to the Centers for Medicare and Medicaid Services (CMS) regarding their Federally Qualified Health Center (FQHC) Prospective Payment System (PPS) proposed rule.    BIO’s comments...
December 18, 2013
December 16, 2013 Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: Docket No. FDA-2013-N-1276: Meta-Analyses of Randomized Controlled Clinical Trials (RCTs) for the...
December 12, 2013
U.S. HOUSE OF REPRESENTATIVES COMMITTEE ON OVERSIGHT & GOVERNMENT REFORM SUBCOMMITTEE ON ENERGY POLICY, HEALTH CARE & ENTITLEMENTS DECEMBER 12, 2013 “FDA CHECK-UP: DRUG DEVELOPMENT AND MANUFACTURING CHALLENGES” Chairman...
December 5, 2013
Thursday, December 5, 2013 U.S. Environmental Protection Agency’s Public Hearing for the 2014 Standards for the Renewable Fuel Standard Program, Docket Number: EPA-HQ-OAR-2013-0427 Hyatt Regency, Crystal City, 2799 Jefferson Davis...
November 27, 2013
The Biotechnology Industry Organization (BIO) thanks the European Medicines Agency (EMA) for the opportunity to submit comments on the revised “Guideline on similar biological medicinal products containing biotechnology-derived proteins as...
November 20, 2013
BIO commends the Brazilian Government for its efforts to revisit its policies with the goal of developing a legal framework that stimulates research and development based on Brazil’s rich genetic heritage. Given that technological advances...
November 18, 2013
Dear Sir/Madam: The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to submit comments on the “Draft Guidance for Industry on Patient Counseling Information Section of Labeling...
November 6, 2013
November 6, 2013 The Honorable Robert Menendez 528 Hart Senate Office Building United States Senate Washington, D.C. 20510    The Honorable Patrick Toomey 248 Russell Senate Office Building United...